[HTML][HTML] Fundamentals of OA. An initiative of Osteoarthritis and Cartilage. Obesity and metabolic factors in OA

A Batushansky, S Zhu, RK Komaravolu, S South… - Osteoarthritis and …, 2022 - Elsevier
Objective Obesity was once considered a risk factor for knee osteoarthritis (OA) primarily for
biomechanical reasons. Here we provide an additional perspective by discussing how …

Metabolomics: A scoping review of its role as a tool for disease biomarker discovery in selected non-communicable diseases

AV Aderemi, AO Ayeleso, OO Oyedapo, E Mukwevho - Metabolites, 2021 - mdpi.com
Metabolomics is a branch of 'omics' sciences that utilises a couple of analytical tools for the
identification of small molecules (metabolites) in a given sample. The overarching goal of …

Causality of genetically determined metabolites and metabolic pathways on osteoarthritis: a two-sample mendelian randomization study

Y Gu, Q Jin, J Hu, X Wang, W Yu, Z Wang… - Journal of Translational …, 2023 - Springer
Background Osteoarthritis (OA) is one of the most prevalent musculoskeletal diseases and is
the leading cause of pain and disability in the aged population. However, the underlying …

Mesenchymal stem cell-derived exosomal microRNA-136-5p inhibits chondrocyte degeneration in traumatic osteoarthritis by targeting ELF3

X Chen, Y Shi, P Xue, X Ma, J Li, J Zhang - Arthritis research & therapy, 2020 - Springer
Background Emerging evidence suggests that microRNAs (miRs) are associated with the
progression of osteoarthritis (OA). In this study, the role of exosomal miR-136-5p derived …

Collagen type II: From biosynthesis to advanced biomaterials for cartilage engineering

Z Wu, SH Korntner, AM Mullen, DI Zeugolis - Biomaterials and Biosystems, 2021 - Elsevier
Collagen type II is the major constituent of cartilage tissue. Yet, cartilage engineering
approaches are primarily based on collagen type I devices that are associated with …

Current models for development of disease-modifying osteoarthritis drugs

MJ Makarczyk, Q Gao, Y He, Z Li, MS Gold… - … Engineering Part C …, 2021 - liebertpub.com
Osteoarthritis (OA) is a painful and disabling disease that affects millions of people
worldwide. Symptom-alleviating treatments exist, although none with long-term efficacy …

Characterization of synovial fluid metabolomic phenotypes of cartilage morphological changes associated with osteoarthritis

AK Carlson, RA Rawle, CW Wallace, EG Brooks… - Osteoarthritis and …, 2019 - Elsevier
Objective Osteoarthritis (OA) is a multifactorial disease with etiological heterogeneity. The
objective of this study was to classify OA subgroups by generating metabolomic phenotypes …

Germ‐Free C57BL/6 Mice Have Increased Bone Mass and Altered Matrix Properties but Not Decreased Bone Fracture Resistance

G Vahidi, M Moody, HD Welhaven… - Journal of Bone and …, 2023 - academic.oup.com
The gut microbiome impacts bone mass, which implies a disruption to bone homeostasis.
However, it is not yet clear how the gut microbiome affects the regulation of bone mass and …

Utilizing metabolomics to identify potential biomarkers and perturbed metabolic pathways in osteoarthritis: A systematic review

PM Van Pevenage, JT Birchmier, RK June - Seminars in arthritis and …, 2023 - Elsevier
Purpose Osteoarthritis (OA) is a joint disease that is clinically diagnosed using components
of history, physical exam, and characteristic radiographic findings, such as joint space …

Understanding osteoarthritis pathogenesis: a multiomics system-based approach

A Ratneswaran, JS Rockel… - Current opinion in …, 2020 - journals.lww.com
To address the complexity of osteoarthritis, integration of multitissue analyses by multiomics
approaches with the inclusion of longitudinal clinical data is necessary for a comprehensive …